140 related articles for article (PubMed ID: 11380561)
1. p53 protein expression and oestrogen and progesterone receptor status in invasive ductal breast carcinomas.
Ioakim-Liossi A; Karakitsos P; Markopoulos C; Aroni K; Athanassiadou P; Delivelioti K; Athanassiades P; Vaiopoulos G
Cytopathology; 2001 Jun; 12(3):197-202. PubMed ID: 11380561
[TBL] [Abstract][Full Text] [Related]
2. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
3. Differences in oestrogen and progesterone receptors, HER-2, p53 expression and proliferation in ductal breast cancers in relation to histopathological grade.
Zasławski R; Surowiak P; Paluchowski P; Dziegiel P; Maciejczyk A; Pudełko M; Wojnar A; Zabel M
Folia Morphol (Warsz); 2005 Feb; 64(1):9-15. PubMed ID: 15832264
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast.
Baqai T; Shousha S
Histopathology; 2003 May; 42(5):440-7. PubMed ID: 12713620
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of pleomorphic lobular carcinoma: higher expression of p53 and chromogranin and lower expression of ER and PgR.
Radhi JM
Histopathology; 2000 Feb; 36(2):156-60. PubMed ID: 10672061
[TBL] [Abstract][Full Text] [Related]
6. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
7. Expression of pS2 protein and estrogen and progesterone receptor status in breast cancer.
Ioakim-Liossi A; Karakitsos P; Markopoulos C; Aroni K; Delivelioti K; Gogas J; Kyrkou K
Acta Cytol; 1997; 41(3):713-6. PubMed ID: 9167689
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
Francis G; Beadle G; Thomas S; Mengersen K; Stein S
Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275
[TBL] [Abstract][Full Text] [Related]
9. Differentiated expression of estrogen receptors (ER) and progesterone receptors (PgR) in ductal breast cancers.
Wojnar A; Drozdz K; Podhorska-Okołów M; Pudełko M; Szuba A; Zabel M; Dziegiel P
Folia Histochem Cytobiol; 2009; 47(1):55-60. PubMed ID: 19419938
[TBL] [Abstract][Full Text] [Related]
10. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
Park SS; Kim SW
Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
[TBL] [Abstract][Full Text] [Related]
11. p53 protein expression and proliferative activity in ductal breast carcinomas.
Ioakim-Liossi A; Safioleas M; Karakitsos P; Athanassiadou P; Athanassiades P; Gogas J; Nakopoulou L
Cytopathology; 2000 Aug; 11(4):255-61. PubMed ID: 10983725
[TBL] [Abstract][Full Text] [Related]
12. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer.
Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD
Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters.
Ravikumar G; Ananthamurthy A
J Cancer Res Ther; 2014; 10(3):671-5. PubMed ID: 25313758
[TBL] [Abstract][Full Text] [Related]
14. Loss of bcl-2 expression in ductal carcinoma in situ of the breast relates to poor histological differentiation and to expression of p53 and c-erbB-2 proteins.
Quinn CM; Ostrowski JL; Harkins L; Rice AJ; Loney DP
Histopathology; 1998 Dec; 33(6):531-6. PubMed ID: 9870147
[TBL] [Abstract][Full Text] [Related]
15. p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast.
Rudas M; Neumayer R; Gnant MF; Mittelböck M; Jakesz R; Reiner A
Eur J Cancer; 1997 Jan; 33(1):39-44. PubMed ID: 9071897
[TBL] [Abstract][Full Text] [Related]
16. Expression of oestrogen and progesterone receptors, Ki-67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African population.
Mbonde MP; Amir H; Akslen LA; Kitinya JN
East Afr Med J; 2001 Jul; 78(7):360-5. PubMed ID: 11957260
[TBL] [Abstract][Full Text] [Related]
17. [Expression of PTEN, p53 and EGFR in the molecular subtypes of breast carcinoma and
the correlation among them].
Li X; Wang Q; Fu L; Liu M; Yu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 40(9):973-8. PubMed ID: 26408616
[TBL] [Abstract][Full Text] [Related]
18. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract][Full Text] [Related]
19. Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.
Mohammadizadeh F; Ghasemibasir H; Rajabi P; Naimi A; Eftekhari A; Mesbah A
Cancer Biomark; 2009; 5(1):1-8. PubMed ID: 19242056
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of thymidine kinase and cathepsin D in 200 primary breast carcinomas.
Greco S; Marsigliante S; Leo G; Storelli C
Cancer Lett; 2000 Nov; 160(1):13-9. PubMed ID: 11098079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
